Nektar Therapeutics (NASDAQ:NKTR)
| 21.35 Delayed Data As of 3:59pm ET |  -0.50 / -2.29%Today’s Change | 13.63 Today|||52-Week Range 28.60 | -1.09% Year-to-Date |
Latest NKTR News | Press Releases
No recent news for Nektar Therapeutics.
Today’s Trading
| Previous close | 21.85 |
| Today’s open | 21.81 |
| Day’s range | 21.31 - 22.00 |
| Volume | 45,463 |
| Average volume (3 months) | 1,088,711 |
| Market cap | $3.9B |
Data as of 3:59pm ET, 08/10/2020
Growth & Valuation
| Earnings growth (last year) | -162.69% |
| Earnings growth (this year) | -9.16% |
| Earnings growth (next 5 years) | -7.38% |
| Revenue growth (last year) | -90.40% |
| P/E ratio | NM |
| Price/Sales | 32.96 |
| Price/Book | 2.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MNTAMomenta Pharmaceutic... | -4.44 | -13.46% |
| HALOHalozyme Therapeutic... | -0.29 | -1.00% |
| MORMorphoSys AG | -0.36 | -1.15% |
| BPMCBlueprint Medicines ... | +0.87 | +1.17% |
Data as of 3:59pm ET, 08/10/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.67 |
| Annual revenue (last year) | $114.6M |
| Annual profit (last year) | -$440.7M |
| Net profit margin | -384.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
